Sumayang, Mylen S.

HRN: 23-37-37  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/06/2024
CEFUROXIME 1.5GM (VIAL)
01/06/2024
01/13/2024
IVT
1.5 Gms
On Call To OR
LTCS
Waiting Final Action 
01/06/2024
CEFUROXIME 1.5GM (VIAL)
01/06/2024
01/07/2024
IV
1.5
Q8
Surgical Prophylaxis Sp Repeat LTCS
Waiting Final Action 
01/06/2024
CEFUROXIME 500MG (TAB)
01/07/2024
01/13/2024
PO
500 Mg Tab
BID
Surgical Prophylaxis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: